Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 106 of the 113 references it cites were found in a registry or an index; 22 of the 95 sources its claims cite were checked for support.

A randomized controlled trial of a group acceptance-based intervention for cancer survivors experiencing anxiety at re-entry ('Valued Living'): Study protocol

Open access

Abstract

Background: Anxiety is a common concern of cancer survivors during the transition from active cancer treatment to cancer survivorship (the re-entry phase). This paper presents the study protocol for a novel group-based behavioral intervention to improve mental health, well-being, and medical use outcomes among anxious cancer survivors at re-entry. Methods/Design: This two-armed, prospective randomized controlled trial will randomize a minimum of 100 re-entry-phase cancer survivors with moderate to high anxiety to the intervention or a usual care control condition. The intervention is delivered in a group format over 7 weeks; content is based on Acceptance and Commitment Therapy (ACT), an acceptance, mindfulness, and values-based intervention. Participants will be recruited from community cancer care centers and the intervention will be led by the onsite clinical social workers. Participants will be assessed at baseline, mid-intervention, post-intervention, and 3- and 6-month follow-up. ACT participants will complete process measures before the beginning of group sessions 2, 4, and 6; all participants will complete the process measures during the regular assessments. The primary outcome is anxiety symptoms; secondary outcomes include anxiety disorder severity, fear of recurrence, depressive symptoms, cancer-related trauma symptoms, sense of life meaning, vitality/fatigue, and medical utilization. Discussion: This clinical trial will provide valuable evidence regarding the efficacy of the group ACT intervention in community oncology settings. Trial registration: Clinicaltrials.gov NCT02550925. © 2019 The Author(s).

Overview

CoChat Summary

## TL;DR

This paper is a study protocol for a two-armed randomized controlled trial testing whether a 7-week, group Acceptance and Commitment Therapy intervention (“Valued Living”) improves anxiety and related outcomes in anxious cancer survivors at re-entry. It plans to randomize at least 100 adults to Valued Living or usual care and follow them through 6 months.

## Key findings

  • Not stated in the paper.
  • The trial will randomize a minimum of 100 re-entry-phase cancer survivors with moderate to high anxiety in a 1:1 allocation to ACT or usual care.
  • The intervention consists of 7 weekly group sessions of 2 hours each; participants are assessed at baseline, mid-intervention, post-intervention, 3 months, and 6 months.
  • The primary outcome is HADS anxiety symptoms; secondary outcomes include anxiety disorder severity, fear of recurrence, depressive symptoms, cancer-related trauma symptoms, sense of life meaning, vitality/fatigue, and medical utilization.

## Methods

  • Design: Two-armed, prospective randomized controlled trial comparing group ACT (“Valued Living”) with an enhanced usual care control.
  • Sample/data: At least 100 adults (age 21+) in the Greater Boulder/Denver area who completed primary cancer treatment 6 weeks to 24 months earlier, screened positive for anxiety, and met additional eligibility criteria; exclusions include current moderate to high suicide risk, psychiatric hospitalization or suicide attempt in the past 5 years, and chronic untreated trauma unrelated to cancer.
  • Analysis: The protocol specifies multilevel mixed modeling with intent-to-treat and intervention completer analyses, plus time-lagged models for process measures and moderation/subgroup analyses.

## Limitations

  • The paper states that, because this is the first randomized trial of Valued Living, comparison to a more active condition was considered premature.
  • The text implies a limitation of modest sample size and a single geographic region/community oncology setting; this is evident from the protocol design and recruitment setting, not stated as a formal limitation.
  • The protocol is not an outcomes paper, so clinical effectiveness results are not yet available; this is evident from the text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12885-019-5289-x

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

15 Valid · 1 Not valid · 27 Not checked · 26 Own results and interpretations

14 more claims · 2 with their cited sources checked

Create a free account to see all 69 claims and to verify the 3 references still open.

See all claims — free account
  • It may state two separate claims as one. 27
  • Probably not a substantial claim. 32

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 113 references

Research works printed but not linked: 4

  1. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in translation. Institute of Medicine Report. Washington, DC: National Academies Press; 2006.
  2. Rechis R, Boerner L. How cancer has affected post-treatment survivors: a livestrong report; 2010.
  3. Polk KL, Schoendorff B. The ACT matrix: a new approach to building psychological flexibility across settings and populations. Oakland: Context Press; 2014.
  4. Sheehan DV. MINI International Neuropsychiatric Interview, English Version 7.0.0 for DSM-5; 2014.

Cited by

See all 20

Metadata

Authors
Arch, J. J., Mitchell, J. L., Genung, S. R., Fisher, R., Andorsky, D. J., & Stanton, A. L.
Affiliations
  • University of Colorado Boulder (US)
  • Rocky Mountain Cancer Centers (US)
  • University of California, Los Angeles (US)
Corresponding author
Arch, Joanna J.
Venue
BMC Cancer
Published
2019-01-18
Volume
19
Issue
1
Pages
89-89
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2914540347
Cited by
20
References
113
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 6 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 3
FWCI
1.01
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • CU Scholar (University of Colorado Boulder) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
American Cancer Society (RSG-15-020-01–CPPB)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
Keywords
cancer survivors, anxiety, acceptance and commitment therapy, group intervention, valued living, fear of recurrence, depressive symptoms, meaning of life, fatigue, medical utilization, community oncology, clinical social workers
MeSH terms
Cancer Survivors, Adaptation, Psychological, Adult, Aged, Aged, 80 and over, Anxiety, Female, Humans, Male, Middle Aged, Neoplasms, Prospective Studies, Quality of Life, Surveys and Questionnaires, Randomized Controlled Trials as Topic, Treatment Outcome, Young Adult, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized controlled trial of a group acceptance-based intervention for cancer survivors experiencing anxiety at re-entry ('Valued Living'): Study protocol. https://app.cochat.ai/papers/10.1186/s12885-019-5289-x
The paper
Arch, J. J., Mitchell, J. L., Genung, S. R., Fisher, R., Andorsky, D. J., & Stanton, A. L. (2019). A randomized controlled trial of a group acceptance-based intervention for cancer survivors experiencing anxiety at re-entry ('Valued Living'): Study protocol. BMC Cancer. https://doi.org/10.1186/s12885-019-5289-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.